Josh J. Carlson

PCN9 VALUE OF RESEARCH ANALYSES IN RESEARCH PRIORITIZATION OF CANCER GENOMIC APPLICATIONS

Josh J. Carlson, Rahber Thariani, Joshua A. Roth, 2011 .

Alternative Approaches to Quality-Adjusted Life-Year Estimation Within Standard Cost-Effectiveness Models: Literature Review, Feasibility Assessment, and Impact Evaluation.

Josh J. Carlson, Eunice Kim, Elizabeth Brouwer, 2020, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

A Structured Approach to Prioritizing Cancer Research Using Stakeholders and Value of Information

Josh J. Carlson, Patricia A. Deverka, Dawn L. Hershman, 2018 .

Cost-Effectiveness of Implementing Clonoseq NGS-MRD Testing Using the Emory MRD Decision Protocol in Multiple Myeloma

Josh J. Carlson, M. Zimmermann, Audrey Demaree, 2020 .

Feasibility And Acceptability Of Minimal Modeling Value Of Information Analyses For Real-Time Prioritization Decisions Within A Large Cancer Clinical Trials Cooperative Group

Josh J. Carlson, Scott D. Ramsey, Dl Veenstra, 2015 .

Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World Experiment

Josh J. Carlson, Scott D. Ramsey, Anirban Basu, 2019, PharmacoEconomics.

Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States

David Veenstra, Josh J. Carlson, Anirban Basu, 2019, PharmacoEconomics.

The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis

Josh J. Carlson, Joshua A. Roth, J. Roth, 2013, Breast Cancer Research and Treatment.

Cost Effectiveness of Pharmacogenomics

Josh J. Carlson, Rahber Thariani, D. Veenstra, 2012, PharmacoEconomics.